Search Results

The Glucose Meter-Check Control Solution for AgaMatrix is intended for use to verify the performance and correct operation of the AgaMatrix blood glucose monitoring test systems utilizing the WaveSense family of blood glucose test strips. Glucose Meter-Check Control Solution for AgaMatrix is intended for use by healthcare professionals and people with diabetes mellitus at home.

Glucose Meter-Check Control Solution for AgaMatrix is a buffered aqueous solution with glucose containing no ingredients of biological origin, or in concentrations qualifying as a controlled product under the Controlled Products Regulation. The Glucose Meter-Check Control Solution is formulated for optimal performance on AgaMatrix glucose meters utilizing the WaveSense family of test strips.

The provided text describes a 510(k) summary for the Glucose Meter-Check Control Solution for AgaMatrix. It details the device's characteristics, intended use, and comparison to a predicate device for substantial equivalence. However, it does not contain detailed information about specific acceptance criteria or the results of a study designed to prove the device meets these criteria.

The document mentions "Tests were conducted to verify specific performance requirements" in section (b)(1) within part {1}, listing categories like "Closed bottle stability (Shelf-life)," "Stability after opening (Use-life)," "Transport Stability," and "Test response." However, it does not provide the actual acceptance criteria for these tests or the reported performance data from these tests.

Therefore, I cannot populate the table or answer most of the specific questions as the required information is not present in the provided text.

Here is a summary of what can be extracted and what is missing:

1. Table of Acceptance Criteria and Reported Device Performance

Not available in the provided text. The document states that tests were conducted for stability and test response, but it does not specify the acceptance criteria (e.g., "glucose concentration should be within X% of target") or the actual results obtained from these tests.

2. Sample size used for the test set and the data provenance

Not available in the provided text. There is no mention of sample sizes or data provenance (country of origin, retrospective/prospective) for any testing.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

Not applicable/available. This device is a control solution for glucose meters, not an AI/diagnostic imaging device requiring expert ground truth for interpretation of complex data. The "ground truth" for a control solution would typically be its known glucose concentration, established through a traceable analytical method rather than expert consensus on images or clinical cases.

4. Adjudication method for the test set

Not applicable/available. Adjudication methods like 2+1 or 3+1 are typically used for expert consensus in diagnostic imaging studies. This is not relevant for a glucose control solution.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

Not applicable. This device is a control solution for glucose meters, not an AI-assisted diagnostic tool. Therefore, MRMC studies and AI effect sizes are not relevant.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

Not applicable. This device is a control solution, not an algorithm.

7. The type of ground truth used

For a control solution, the ground truth would be the known, analytically determined concentration of glucose within the solution. While the document doesn't explicitly state "analytically determined glucose concentration was used as ground truth," this is the standard for such products.

8. The sample size for the training set

Not applicable. This is a control solution, not a machine learning model, so there is no "training set."

9. How the ground truth for the training set was established

Not applicable. As there is no training set.

Ask a specific question about this device

The Liberty™ Blood Glucose Monitoring System is intended to quantitatively measure blood glucose levels, also known as blood sugar, from fresh capillary whole blood samples taken from the fingertips, palm, or forearm. The Liberty, TM Test Strips are for in vitro diagnostic (outside of the body) use only. The Liberty™ System is not intended for use with neonates.

AgaMatrix Liberty " Blood Glucose Monitoring System is intended for the quantitative measurement of glucose in fresh capillary whole blood from the fingertip, palm, or forearm. Testing is done outside the body (in vitro diagnostic use). It is indicated for use at home (over the counter (OTC) ) by persons with diabetes, or in a clinical setting by healthcare professionals, as an aid to monitor the effectiveness of diabetes control. It is not intended for use with neonates.

AgaMatrix Liberty™ Blood Glucose Meter is intended for use with AgaMatrix Liberty™ Blood Glucose Test Strips for the quantitative measurement of glucose in frearians courty whole blood. Testing sdone outside the body (in viro diagnostic use). It is indicated for use at home (over the counter (OTC) ) by persons with diabetes, or in a clinical setting by healthcare professionals, as an aid to monitor the effectiveress of diabetes control.

AgaMatrix Liberty " Blood Glucose Test Strips are intended for use with AgaMatrix Liberty™ Blood Glucose Meter for the quantitative measurement of glucose in fresh capillary whole blood. Testing is done outside the body (in vitro diagnostic use). It is indicated for use at home (over the counter (OTC) ) by persons with diabetes, or in a clinical setting by healthcare professionals, as an aid to monitor the effective of por diabetes control.

AgaMatix Liberty™ Control Solutions are intended for use with the AgaMarix Libery™ Meter and AgaMatix Liberty™ Test Stri results.

The AgaMatrix Liberty™ Blood Glucose Monitoring System includes a meter with batteries, compact carrying casc, quick start guide, reference guide, owner's booklet, and warranty/registration card. Test Strips, Lancing device, Lancets, and Control Solution are purchased separately.

It is intended for over-the-counter home use by diabetics to monitor their blood glucose levels, or for use in a clinical setting by healthcare professionals. The system tests fresh capillary whole blood. The meter is a portable, battery-operated instrument.

The provided 510(k) summary for the AgaMatrix Liberty™ Blood Glucose Monitoring System (K063409) does not contain detailed information regarding the specific acceptance criteria and the comprehensive study results as typically expected for device validation.

Instead, it states that the device complies with certain ISO and IEC standards, which imply conformance to established performance requirements. However, the specific numerical acceptance criteria (e.g., accuracy percentages, precision limits) and the detailed results of studies demonstrating compliance are not explicitly provided in the given text.

Based on the provided document, here's what can be extracted and what information is missing:

1. A table of acceptance criteria and the reported device performance:

This information is not explicitly stated in the provided text. The document refers to compliance with ISO 15197:2003, which sets performance requirements for blood glucose monitoring systems for self-testing. However, the specific numerical criteria (e.g., accuracy within a certain percentage of a reference method) and the device's measured performance against those criteria are not listed.

2. Sample size used for the test set and the data provenance:

This information is not explicitly stated in the provided text. The document mentions "Testing" but does not detail the sample sizes for patient samples or control samples, nor their country of origin or whether the data was retrospective or prospective.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

This information is not explicitly stated in the provided text. For blood glucose monitoring systems, "ground truth" is typically established by laboratory reference methods, not by expert consensus on visual assessment.

4. Adjudication method for the test set:

This information is not applicable/not explicitly stated in the context of a blood glucose monitoring system's performance testing. Adjudication methods like 2+1 or 3+1 are typically used for subjective assessments (e.g., image interpretation) where multiple readers provide their opinion. For quantitative measurements like blood glucose, accuracy is determined by comparison to a reference method.

5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

This information is not applicable. This device is a blood glucose monitoring system, not an AI-assisted diagnostic imaging device that involves human readers interpreting cases.

6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:

This information is not explicitly stated but is implicitly the primary mode of operation for a blood glucose meter. The "device performance" would inherently be its standalone performance, as it provides a direct measurement rather than an interpretation to a human.

7. The type of ground truth used:

This is not explicitly stated, but for blood glucose monitoring systems, the ground truth is universally established by laboratory reference methods (e.g., YSI analyzer). The document mentions "in vitro diagnostic (outside of the body) use only," which confirms the nature of the testing.

8. The sample size for the training set:

This information is not applicable/not explicitly stated. "Training set" refers to data used to develop and train machine learning models. A blood glucose monitoring system, based on electrochemical principles, does not typically involve a "training set" in the machine learning sense. Its performance is based on its sensor technology and calibration, not learned patterns from a dataset.

9. How the ground truth for the training set was established:

This information is not applicable for the reasons stated in point 8.

Summary of available and missing information:

To get the specific acceptance criteria and detailed study results, one would typically need to refer to a more detailed clinical study report or the full submission documentation to the FDA, which is not provided in this 510(k) summary. The summary focuses on establishing substantial equivalence based on identical technological characteristics and compliance with general standards.

Ask a specific question about this device